The complexity of illnesses such as MS means that a multidimensional approach to treating MS and managing symptoms

The pharmaceutical sponsor of Tecfidera (BG-12), Biogen Idec, has this week reported one case of Progressive Multifocal Leukoencephalopathy

Following a very rich and promising round of grant applications earlier in 2014, MS Research Australia recently held

Researchers from University Hospital Principe de Asturias in Spain have contributed further evidence to suggest that measuring subtle

A group of international researchers from Norway, Italy, Serbia, Sweden, Germany, and Canada have recently reported new data

The International Progressive MS Alliance recently announced its first round of prestigious research grants to 22 investigators in

Each year MS Research Australia welcomes two rounds of applications for Incubator Grant projects. Incubator grants provide seed

A modified version of Interferon-beta1a, recently approved for the treatment of relapsing remitting MS by both the European

Magnetic Resonance Imaging (MRI) scans of brain and spinal cord perform a vital role in the diagnosis and